image
Lexaria Bioscience Corp. LEXX
Healthcare - Biotechnology - NASDAQ - CA
Watchlist
$ 2.01
-5.19 %
$ 35.1 M
Market Cap
-4.9
P/E
CASH FLOW STATEMENT
-5.88 M OPERATING CASH FLOW
-20.53%
Growth Rates
1Year -20.53%
3Years -30.22%
5Years -18.49%
7Years -36.65%
10Years -46.08%
-170 K INVESTING CASH FLOW
6.11%
Growth Rates
1Year 6.11%
3Years -84.87%
5Years -1.77%
7Years -35.62%
10Years 4.69%
1.59 M FINANCING CASH FLOW
3664.42%
Growth Rates
1Year 3664.42%
3Years -16.17%
5Years -3.17%
7Years 17.49%
10Years 18.65%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Lexaria Bioscience Corp.
image
Net Income -6.71 M
Depreciation & Amortization 145 K
Capital Expenditures -170 K
Stock-Based Compensation 170 K
Change in Working Capital 143 K
Others 516 K
Free Cash Flow -6.05 M

Cash Flow

Millions
Aug-2023 Aug-2022 Aug-2021 Aug-2020 Aug-2019 Aug-2018 Aug-2017 Aug-2016 Aug-2015 Oct-2013 Oct-2012 Oct-2011 Oct-2010 Oct-2009 Oct-2008 Oct-2007 Oct-2006 Oct-2005
OPERATING CASH FLOW
Net Income (6.7) (7.4) (4.2) (4.1) (4.2) (6.6) (1.9) (1.3) (1.9) (0.3) (0.3) (0.5) (0.6) (0.8) (1.0) (1.1) (0.5) 75.7 K
Depreciation & Amortization 0.1 0.1 0.1 0.1 60.6 K 2.31 K 1.49 K 619 0 0 0.3 425 1.02 K 1.25 K 0.5 0.1 81.8 K 0
Deferred Income Tax (0.2) 0 (0.5) 0.2 0.2 1.1 0.4 76.3 K 0 0 0 0.4 0 0 33.1 K 0 0 0
Stock Based Compensation 0.2 0.8 0.4 1.1 0.6 2.6 0.1 0.1 0.3 0.8 21.3 K 11.3 K 0.2 0.2 0 75.5 K 0 0
Other Operating Activities 0.5 2.0 92.9 K 100 K 0.2 0.8 0.2 79.5 K 0.2 0.4 0.5 15.7 K 0.2 0.4 0.5 0.7 0.3 0
Change in Working Capital 0.1 (0.4) 63.5 K (0.2) 79.7 K (0.4) (0.3) 0.3 45.7 K 0.3 81.6 K (0.3) 96.8 K 0.2 1.12 K 19.6 K 8.27 K 33.4 K
Cash From Operations (5.9) (4.9) (4.0) (2.7) (3.0) (2.5) (1.5) (0.7) (1.5) 0.3 0.1 (0.2) (0.3) 36.4 K 29 K (0.2) (0.2) 42.3 K
INVESTING CASH FLOW
Capital Expenditures (0.2) (0.1) 79.5 K 33.6 K (0.8) 85.4 K 9.7 K 20.1 K 37 K 91.6 K (0.3) (0.7) (0.3) (0.2) (0.6) (2.1) (1.5) (0.3)
Other Items 0 49.2 K 0.3 6.8 K 0 70 K 0 0 0.7 21 K 0 0 0 0 0.2 0 0 0
Cash From Investing Activities (0.2) (0.2) 0.2 26.8 K (0.8) (0.2) 9.7 K 20.1 K 0.7 70.6 K (0.3) (0.7) (0.3) (0.2) (0.4) (2.1) (1.5) (0.3)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid 0 0 66.7 K 13.8 K 0 0 50 K 95 K 98.7 K 0 (0.4) 0.3 0.4 0.2 84 K 0.7 50 K 2.0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 44.6 K 4.0 0 1.0 0 0 0 0 (0.4) 0 0 0.5 0 (0.2) 0.2 1.0 (0.9)
Cash From Financing Activities 1.6 44.6 K 13.4 2.7 3.3 1.9 4.0 0.5 0.4 (0.4) 0.3 0.9 0.3 79.2 K 0.9 1.1 2.1 1.2
CHANGE IN CASH
Net Change In Cash (4.5) (5.1) 9.6 8.6 K (0.4) (0.8) 2.4 (0.2) (0.4) (0.1) 0.1 31.8 K (0.3) (0.3) 0.6 (1.2) 0.4 0.9
FREE CASH FLOW
Free Cash Flow (6.1) (5.0) (4.1) (2.7) (3.8) (2.6) (1.6) (0.7) (1.5) 0.2 (0.1) (0.9) (0.6) (0.3) (0.6) (2.3) (1.7) (0.3)